Jesse Gelsinger’s is a cautionary tale in gene therapy research, again in the spotlight due to COVID-19.
Author: Melina Walling, Arizona Republic
Dementia is difficult and costly to diagnose. It’s even harder to study. Here’s why there’s no cure yet
About one in nine seniors in U.S. have Alzheimer’s, the most common type of dementia. Here’s how it affects the brain and changes people’s view of the world.